Antibody persistence six years after two doses of combined hepatitis A and B vaccine

Abstract Persistent immunity to hepatitis A and hepatitis B antibodies six years after vaccination of adolescents (aged 12–15 years) with a combined hepatitis A and B (HAB) vaccine following a 0, 6 month or a 0, 12 month schedule was assessed. Yearly (Year-2–6) serum samples were tested for anti-HAV...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2010-03, Vol.28 (10), p.2222-2226
Main Authors: Burgess, Margaret A, McIntyre, Peter B, Hellard, Margaret, Ruff, Tilman A, Lefevre, Inge, Bock, Hans L
Format: Article
Language:English
Subjects:
Adolescent
Adolescents
Age
Allergy and Immunology
Antibodies
Antibody persistence
Applied microbiology
Biological and medical sciences
Child
Combined hepatitis A and hepatitis B vaccine
Combined vaccines
Female
Fundamental and applied biological sciences. Psychology
Hepatitis
Hepatitis A
Hepatitis A Antibodies - blood
Hepatitis A Vaccines - immunology
Hepatitis B
Hepatitis B Antibodies - blood
Hepatitis B Vaccines - immunology
Hepatitis B virus
Human viral diseases
Humans
Immunity
Immunization
Immunization, Secondary - methods
Infectious diseases
Liver cirrhosis
Long-term protection
Male
Medical sciences
Microbiology
Schedules
Standard deviation
Studies
Teenagers
Time Factors
Vaccination
Vaccination - methods
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Vaccines, Combined - immunology
Viral diseases
Viral hepatitis
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Persistent immunity to hepatitis A and hepatitis B antibodies six years after vaccination of adolescents (aged 12–15 years) with a combined hepatitis A and B (HAB) vaccine following a 0, 6 month or a 0, 12 month schedule was assessed. Yearly (Year-2–6) serum samples were tested for anti-HAV and anti-HBs using EIA. Subjects with anti-HBs concentrations
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2009.12.053